Johnson & Johnson News and Healthcare Innovation

247.41
6.4400
2.54 %
Daily range
Weekly range
  • Ashutosh Sureka
  • 1 hour ago
Johnson & Johnson raises outlook as second-quarter earnings top estimates
Johnson & Johnson is reinforcing its case as a defensive healthcare holding after lifting full-year guidance despite a share decline following its second-quarter results. The update points to ...
  • Emilio Ghigini
  • 1 hour ago
Can Johnson & Johnson stock avoid deeper losses as support pressure builds?
Johnson & Johnson (JNJ) stock is trading at $246.35 after a daily decline of 3.26%. The price currently sits below its key moving averages on the short- and medium-term, ...
  • Ashutosh Sureka
  • 5 hours ago
U.S. markets edge higher as oil rises and earnings drive volatility
Investor focus is shifting to corporate guidance as the earnings season accelerates and uneven stock reactions test confidence in stretched valuations. At the same time, rising oil prices linked ...
  • Dan Blystone
  • 13.07.2026
Johnson & Johnson stock edges higher with strong momentum shown by MACD signal: weekly analysis
Johnson & Johnson (JNJ) closed the week at $256.61, marking a modest decline of $0.45 (0.03%) from the previous week's close and holding at the very bottom of its ...
  • Ciaran Ryan
  • 13.07.2026
White House plans utility, data center pledge on AI power costs
The White House is preparing a new voluntary pledge that seeks to keep the fast-rising electricity needs of artificial intelligence from pushing up power bills for households and businesses. The ...
  • Ashutosh Sureka
  • 10.07.2026
U.S. stocks rise as investors await bank earnings kickoff
U.S. equities are edging higher at the end of the week as investors position for a heavy run of second-quarter results across banking, healthcare, semiconductors and streaming. The earnings ...
  • Ciaran Ryan
  • 10.07.2026
Intel share decline keeps chipmaker in focus as CNBC club eyes further buying
Semiconductor stocks are losing ground as investors rotate within the chip sector and assess new opportunities tied to AI demand. Intel is drawing particular attention after a sharp weekly drop, ...
  • Ashutosh Sureka
  • 07.07.2026
Johnson & Johnson stock surges over 3% amid bullish momentum and institutional investment
Johnson & Johnson (JNJ) rallied 3.03% as resilient financial results and robust cash flow fueled renewed buying interest. The move is supported by the stock trading well above its 20-day, 50-day, ...
  • Ashutosh Sureka
  • 07.07.2026
What's behind Johnson & Johnson's latest stock surge?
Johnson & Johnson (JNJ) stock is trading at $268.2, up 3.42% today. The price sits above its key moving averages, signaling strong near-term momentum and broad technical ...
  • Sholanke Dele
  • 06.07.2026
JNJ stock slides slightly as shares trade above key moving averages: weekly outlook
Johnson & Johnson (JNJ) shares are currently trading at $257.21, down $5.19 or 1.92% over the past week. The price remains well above its weekly MA-20 ($237.26), MA-50 ...
  • Ashutosh Sureka
  • 29.06.2026
Eli Lilly, Regeneron join FDA pilot to speed U.S. drug plant reviews
The U.S. Food and Drug Administration is selecting an initial group of drugmakers for a pilot program aimed at shortening the review process for new domestic pharmaceutical manufacturing sites. ...
  • Ashutosh Sureka
  • 29.06.2026
Johnson & Johnson expands U.S. investment as tax policy backs domestic manufacturing
Republican-backed Working Families Tax Cuts are being presented as strengthening the investment climate for U.S. manufacturers and workers. Johnson & Johnson says the policy framework supports its ...
  • Andreas Kristo
  • 29.06.2026
JNJ stock edges higher as price consolidates near resistance: weekly outlook
Johnson & Johnson (JNJ) is currently trading at $254.95, having increased by $0.89 or 0.36% over the past week. The stock sits well above its weekly MA-20 ($236.31), ...
  • Ciaran Ryan
  • 26.06.2026
Healthcare stocks rally as sector rotation lifts Cardinal Health, J&J and Eli Lilly
A rotation away from AI-linked trades is pushing healthcare shares sharply higher at the end of the week, even as the broader U.S. stock market remains volatile. Cardinal Health, Johnson & Johnson ...
  • Dan Blystone
  • 26.06.2026
Johnson & Johnson stock gains 3.51% as dividend increases to $1.34 per share
Johnson & Johnson (JNJ) stock is trading at $253.35 after a strong surge of 3.51% on the day, marking a clear advance. The price remains well above its key moving ...
  • Dmytro Kharkov
  • 24.06.2026
+3.11% for Johnson & Johnson stock as upbeat 2026 forecast follows robust Q1 results
Johnson & Johnson (JNJ) stock is trading at $238.41, advancing 3.11% for the session. The price currently sits above its key short- and medium-term moving averages, ...
  • Parshwa Turakhiya
  • 19.06.2026
Johnson & Johnson stock dips with sideways action likely in narrow range: weekly review
Johnson & Johnson (JNJ) shares are currently trading at $228.35, reflecting a weekly decline of $11.77, or 4.9%. The price is below the weekly MA-20 at $235.62, just ...
  • Andreas Kristo
  • 12.06.2026
JNJ stock edges higher with $1 billion Firefly Bio acquisition supporting oncology expansion: weekly forecast
Johnson & Johnson (JNJ) is trading at $238.90, finishing the week up $6.15 (2.57%). The asset remains above its weekly MA-20 ($235.47), MA-50 ($207.27), and MA-200 ...
  • Ashutosh Sureka
  • 08.06.2026
Johnson & Johnson charts signal potential pharma breakout as sector momentum strengthens
Pharmaceutical shares are gaining leadership within healthcare as sector momentum improves against the broader market. That shift is supporting expectations that other large-cap drugmakers could ...
  • Ashutosh Sureka
  • 05.06.2026
U.S. Department of State increases Ebola response funding for DRC and Uganda
As the Ebola outbreak response continues in the Democratic Republic of the Congo and Uganda, the U.S. Department of State is adding nearly $38 million to its direct funding effort. The increase ...
  • Ciaran Ryan
  • 05.06.2026
U.S. stocks extend midday sell-off as chipmakers, crypto names and recent listings slide
Defensive sectors are leading the market in Friday midday trading as investors pull back from technology and crypto-linked shares. The sharpest moves include fresh weakness in semiconductor ...